Simplex Trading’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,274
| Closed | -$815 | – | 10305 |
|
|
2023
Q1 | $0 | Sell |
2,274
-1,393
| -38% | -$734 | ﹤0.01% | 10514 |
|
|
2022
Q4 | $1K | Buy |
+3,667
| New | +$2.33K | ﹤0.01% | 9010 |
|
|
2022
Q2 | – | Sell |
-981
| Closed | -$1.25K | – | 11477 |
|
|
2022
Q1 | $2K | Buy |
+981
| New | +$2.33K | ﹤0.01% | 9984 |
|
|
2020
Q3 | – | Sell |
-10,210
| Closed | -$37.5K | – | 8740 |
|
|
2020
Q2 | $34K | Buy |
+10,210
| New | +$48.3K | ﹤0.01% | 5836 |
|
|
2019
Q2 | – | Sell |
-1,989
| Closed | -$23K | – | 8011 |
|
|
2019
Q1 | $10K | Sell |
1,989
-1,530
| -43% | -$7.44K | ﹤0.01% | 6173 |
|
|
2018
Q4 | $10K | Sell |
3,519
-2,223
| -39% | -$12.2K | ﹤0.01% | 5868 |
|
|
2018
Q3 | $46K | Buy |
+5,742
| New | +$44.1K | ﹤0.01% | 5252 |
|
|
2018
Q2 | – | Sell |
-3,222
| Closed | -$33K | – | 8044 |
|
|
2018
Q1 | $27K | Buy |
3,222
+2,658
| +471% | +$28.7K | ﹤0.01% | 3070 |
|
|
2017
Q4 | $7K | Sell |
564
-2,465
| -81% | -$28.3K | ﹤0.01% | 4245 |
|
|
2017
Q3 | $25K | Sell |
3,029
-8,167
| -73% | -$86.3K | ﹤0.01% | 2956 |
|
|
2017
Q2 | $189K | Sell |
11,196
-12,064
| -52% | -$240K | 0.01% | 1236 |
|
|
2017
Q1 | $467K | Buy |
23,260
+17,622
| +313% | +$350K | 0.02% | 712 |
|
|
2016
Q4 | $87K | Buy |
+5,638
| New | +$75.9K | 0.01% | 1654 |
|
Simplex Trading's ZYNE Position: Q2 2023 in Review
Simplex Trading sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2023, closing a stake of 2,274 shares — an estimated $815 sold.
Simplex Trading first reported a position in ZYNE in Q4 2016 and held it in 13 quarters. The position peaked at $467K in Q1 2017. 41 funds tracked by Wall St. Rank hold ZYNE as of Q2 2023.
- Simplex Trading reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2023 after selling out during the quarter.
- Simplex Trading sold 2,274 Zynerba Pharmaceuticals, Inc shares in Q2 2023, an estimated $815.
- Simplex Trading first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2016 and held it in 13 quarters.
- Simplex Trading's Zynerba Pharmaceuticals, Inc position peaked at $467K in Q1 2017.
- 41 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2023.
Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.